Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Additional excipient justification [Dissolution / BCS / IVIVC]

posted by nobody – 2014-11-30 21:44 (3793 d 14:34 ago) – Posting: # 13958
Views: 6,746

afaik only WHO considers (some limited) class II APIs egligilbe for biowaivers. Look up literature for ibuprofen to have details on limitations for this approach, has been discussed here in the past iirc...

Regards

nobody

—
Kindest regards, nobody

Complete thread:

Additional excipient justification srinivasuk 2014-11-30 08:53
- Biowaiver for BCS Class II? Helmut 2014-11-30 14:24
- Additional excipient justificationnobody 2014-11-30 20:44
  - Additional excipient justification Dr_Dan 2014-12-02 09:34
    - Additional excipient justification nobody 2014-12-02 10:38

Admin contact
23,424 posts in 4,927 threads, 1,678 registered users;
23 visitors (0 registered, 23 guests [including 8 identified bots]).
Forum time: 13:19 CEST (Europe/Vienna)

It is true that many scientists are not philosophically minded
and have hitherto shown much skill and ingenuity
but little wisdom. Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz